Open strategic autonomy and crisis resilience in the pharmaceuticals industry. Open strategic autonomy: for some time already, this is the new 'buzzword' in the European Union (EU), after being confronted heavily with a range of existing supply chain vulnerabilities and strategic dependencies. To paraphrase how…